Pacific Biosciences of California, Inc.
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumabl…
Medical - Devices
US, Menlo Park [HQ]
Ratios
15 Sheets · From 2023 to 2009Configuration
Margins, Growth Rates In %
| Ratio | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||||
| Gross Margin | 100.00 | 100.00 | 38.49 | 3.62 | 22.78 | 38.62 | 57.61 | 48.68 | 37.08 | 31.92 | 38.04 | 41.28 | 45.10 | 38.22 | 20.12 | |
| Profit Margin | -64,965.19 | -8,373.12 | -323.03 | -363.56 | -281.37 | -109.19 | -34.16 | -81.99 | -98.63 | -130.44 | -85.62 | 37.27 | -138.85 | -231.43 | -152.97 | |
| Operating Margin | -65,237.04 | -8,377.18 | -324.12 | -363.08 | -275.16 | -103.73 | -31.40 | -78.54 | -96.06 | -128.44 | -110.62 | -132.31 | -136.51 | -237.58 | -154.78 | |
|
EPS Growth
|
-100.44 | 87.56 | 85.60 | 16.75 | 25.44 | 25.40 | 55.32 | -97.62 | -4.82 | 12.64 | 32.90 | 135.29 | -594.44 | -48.32 | 8.33 | |
| EPS USD | -11,333.00 | -1,410.00 | -203.00 | -169.00 | -126.00 | -94.00 | -42.00 | -83.00 | -87.00 | -76.00 | -51.00 | 18.00 | -89.00 | -132.00 | -121.00 | |
| Return on Assets (ROA) | -86.75 | -45.84 | -50.11 | -72.84 | -58.22 | -53.13 | -24.18 | -53.94 | -63.98 | -60.23 | -52.59 | 7.10 | -9.03 | -16.80 | -17.57 | |
| Return on Equity (ROE) | 49.52 | -50.08 | -57.13 | -86.36 | -114.62 | -120.40 | -43.10 | -87.84 | -107.07 | -89.92 | -141.70 | 8.76 | -22.91 | -52.75 | -43.74 | |
| Return on Invested Capital (ROIC) | 49.47 | -49.51 | -56.27 | -84.10 | -94.76 | -80.84 | -33.31 | -63.42 | -80.08 | -75.42 | -68.23 | -33.83 | -6.70 | -18.95 | -18.66 | |
| Solvency | ||||||||||||||||
| Equity Ratio | -100 | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Debt/Assets | - - | 0.99 | 1.34 | 2.15 | 11.72 | 20.53 | 9.81 | 23.72 | 13.84 | 12.30 | 54.99 | 11.19 | 47.91 | 54.18 | 51.68 | |
| Debt/Equity | - - | 1.09 | 1.53 | 2.55 | 23.07 | 46.53 | 17.49 | 38.63 | 23.15 | 18.36 | 148.19 | 13.81 | 121.55 | 170.08 | 128.66 | |
| Debt/EBITDA | 106.27 | 107.06 | 53.62 | 49.90 | 14.62 | 37.77 | 129.93 | 0.98 | 55.16 | 4.18 | -12.63 | 270.51 | -276.87 | -212.76 | -271.44 | |
|
Debt/Capitalization
|
- - | 1.07 | 1.51 | 2.48 | 18.75 | 31.75 | 14.89 | 27.87 | 18.80 | 15.51 | 59.71 | 12.13 | 54.86 | 62.97 | 56.27 | |
| Long-Term Debt/Capitalization | - - | 1.04 | 1.43 | 2.33 | 18.54 | 20.45 | 16.89 | 15.98 | 13.67 | 11.39 | 52.90 | 11.13 | 54.66 | 62.71 | 55.99 | |
| Interest Debt per Share USD | - - | 0.31 | 0.05 | 0.05 | 0.29 | 0.40 | 0.21 | 0.40 | 0.22 | 0.17 | 0.55 | 0.27 | 4.78 | 4.33 | 3.61 | |
| Debt Growth | -100.00 | - - | -3.66 | -4.79 | 472.86 | -11.50 | 5.83 | 7.75 | -15.34 | 7.51 | 320.71 | -31.90 | 2,170.88 | 0.38 | -2.45 | |
| Liquidity | ||||||||||||||||
| Current Ratio | 1,113.49 | 1,406.50 | 1,030.15 | 780.03 | 560.67 | 373.97 | 504.13 | 322.77 | 455.36 | 647.07 | 371.17 | 972.19 | 1,327.58 | 1,111.60 | 780.86 | |
| Quick Ratio | 1,101.50 | 1,362.84 | 939.26 | 701.36 | 511.08 | 332.67 | 620.95 | 246.93 | 549.70 | 545.28 | 383.96 | 1,569.89 | 1,283.05 | 1,028.53 | 703.29 | |
| Cash Ratio | 1,059.89 | 708.49 | 303.80 | 315.68 | 116.88 | 115.75 | 375.20 | 49.64 | 281.74 | 92.61 | 224.86 | 873.70 | 553.16 | 422.65 | 189.64 | |
| Operating Cash Flow Ratio | -800 | -500 | -500 | -500 | -100 | -100 | -200 | -200 | -300 | -300 | -300 | - - | -100 | -300 | -200 | |
| Turnover | ||||||||||||||||
| Inventory Turnover | - - | - - | 134.23 | 261.08 | 216.54 | 328.12 | 359.03 | 297.77 | 254.97 | 299.42 | 423.04 | 325.56 | 291.28 | 157.34 | 282.62 | |
| Receivables Turnover | - - | 490.91 | 743.10 | 920.73 | 1,026.26 | 1,779.04 | 1,768.96 | 794.27 | 695.81 | 914.79 | 595.38 | 468.57 | 538.40 | 682.98 | 547.65 | |
| Payables Turnover | - - | - - | 439.25 | 838.12 | 1,267.44 | 663.20 | 828.22 | 556.93 | 646.75 | 794.69 | 672.98 | 1,294.41 | 651.27 | 659.04 | 1,063.44 | |
|
Asset Turnover
|
0.13 | 0.55 | 15.51 | 20.04 | 20.69 | 48.66 | 70.77 | 65.79 | 64.87 | 46.18 | 61.42 | 19.06 | 6.50 | 7.26 | 11.48 | |
| Fixed Turnover | 1.89 | 13.60 | 184.06 | 181.33 | 305.12 | 917.95 | 1,085.42 | 623.04 | 246.49 | 230.76 | 144.51 | 143.83 | 164.95 | 157.73 | 290.50 | |
| Coverage | ||||||||||||||||
| Interest Coverage | - - | - - | - - | - - | -3,129.26 | -2,222.56 | -995.69 | -2,202.97 | -3,073.74 | -4,167.85 | -3,850.82 | -39,095.51 | -1,421.89 | -2,075.01 | -2,163.88 | |
| Asset Coverage | - - | 9,300 | 6,800 | 4,100 | 700 | 700 | 700 | 700 | 900 | 1,000 | 200 | 900 | 100 | 100 | 100 | |
| Cash Flow Coverage (CFGR) | - - | -4,016.99 | -3,519.28 | -2,757.43 | -186.92 | -201.32 | -372.33 | -207.67 | -338.71 | -317.16 | -96.23 | 42.09 | -11.56 | -27.49 | -29.54 | |
| EBITDA Coverage | - - | - - | - - | - - | -2,800 | -2,000 | -1,700 | -2,000 | -3,000 | -4,100 | -3,800 | -38,300 | -1,400 | -2,000 | -1,900 | |
| Dividend Coverage | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Time Interest Earned (TIE) | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Market Prospects | ||||||||||||||||
| Dividend Yield | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Earnings Yield | -689.39 | -88.65 | -72.52 | -99.70 | -24.15 | -11.97 | -3.19 | -21.96 | -33.04 | -10.27 | -9.93 | 0.66 | -4.35 | -16.17 | -12.33 | |
|
Price/Earnings (P/E)
|
-14.51 | -112.80 | -137.90 | -100.30 | -414.11 | -835.13 | -3,132.29 | -455.48 | -302.64 | -973.68 | -1,007.45 | 15,258.82 | -2,298.88 | -618.36 | -811.16 | |
| Price/Earnings Growth (PEG) | -0.14 | 1.29 | 1.61 | 5.99 | 16.28 | 32.88 | 56.62 | -4.67 | -62.80 | 77.01 | 30.63 | -112.78 | 3.87 | -12.80 | 97.34 | |
|
Price/Book (P/B)
|
-7.18 | 56.50 | 78.79 | 86.62 | 474.65 | 1,005.52 | 1,350.03 | 400.11 | 324.03 | 875.52 | 1,427.59 | 1,337.31 | 526.70 | 326.18 | 354.78 | |
| Price/Tangible Book (P/TB) | -7.18 | 56.50 | 78.79 | 86.62 | 474.65 | 1,005.52 | 1,350.03 | 400.11 | 324.03 | 875.52 | 1,427.59 | 1,337.31 | 526.70 | 326.18 | 354.78 | |
| Price/Sales (P/S) | 9,423.64 | 9,445.26 | 445.46 | 364.65 | 1,165.18 | 911.85 | 1,070.05 | 373.44 | 298.50 | 1,270.10 | 862.56 | 5,686.88 | 3,192.09 | 1,431.06 | 1,240.82 | |
|
Price/Cash Flow (P/CF)
|
-17.00 | -129.61 | -146.49 | -123.33 | -1,100.66 | -1,073.53 | -2,073.15 | -498.70 | -413.22 | -1,503.28 | -1,001.11 | 23,004.42 | -3,747.16 | -697.58 | -933.45 | |
| Price/Free CF (P/FCF) | -15.90 | -124.25 | -134.38 | -120.66 | -1,068.12 | -1,040.99 | -1,950.59 | -444.94 | -357.92 | -1,462.47 | -966.12 | 24,298.92 | -3,557.39 | -655.42 | -903.48 | |
| Price/Operating CF (P/OCF) | -17.00 | -129.61 | -146.49 | -123.33 | -1,100.66 | -1,073.53 | -2,073.15 | -498.70 | -413.22 | -1,503.28 | -1,001.11 | 23,004.42 | -3,747.16 | -697.58 | -933.45 |